BIOMAT Database Logo BIOMAT Database Logo

[Quantitative structure-activity relationships of the inhibition of Escherichia coli bacteria (1515) by 5-(substituted-benzyl)-2,4-diaminopyrimidines]. 1987

Z X Fang, and R L Li, and Y Qian, and H L Liang

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Z X Fang, and R L Li, and Y Qian, and H L Liang
Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
February 1988, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
May 1981, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
November 1980, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
January 1977, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
[Structure-activity relationships of the inhibition of Escherichia coli dihydrofolate reductase (MB1428) by 5-(substituted phenyl) thio and 5-(substituted phenyl) seleno-2,4-diaminopyrimidines].
March 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Partition coefficients of 5-(substituted benzyl)-2,4-diaminopyrimidines.
January 1982, Arzneimittel-Forschung,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase.
June 1979, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
July 1982, Journal of medicinal chemistry,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.
October 1988, Molecular and biochemical parasitology,
Z X Fang, and R L Li, and Y Qian, and H L Liang
Application of neural networks: quantitative structure-activity relationships of the derivatives of 2,4-diamino-5-(substituted-benzyl)pyrimidines as DHFR inhibitors.
August 1992, Journal of medicinal chemistry,
Copied contents to your clipboard!